28-Jan-2015 - Johnson Matthey saw demand for ADHD APIs increase in the third quarter, while sales of its pain management ingredients and bulk opiates declined.
27-Jan-2015 - A coating and packaging expansion at a facility in Germany will feed the demand for end-to-end softgel services, Catalent Pharma Solutions says.
26-Jan-2015 - AMRI has won a contract to manufacture a solid dose injection (SDI) formulation for Glide Technologies from its newly acquired UK aseptic facility.
26-Jan-2015 - Indian CMO Neuland Labs has passed a US FDA audit at one of its two API plants.
22-Jan-2015 - Big Pharma firms like AbbVie are partnering with delivery device makers to guard against biosimilar competition according to Unilife CEO, Alan Shortall.
22-Jan-2015 - Biopharma outsourcing growth has helped to boost the bottom line of Lonza, the world’s largest manufacturer of drug ingredients, though a topsy-turvy Swiss franc has caused the company to hold...
21-Jan-2015 - Abenza subsidiary Antitope has extended its relationship and will provide manufacturing cell lines for two developing HIV vaccines from the French National Institute of Health and Medical Research (INSERM); the...
20-Jan-2015 - AMRI has won a $38m federal contract to support the National Institutes of Health Drug Manufacturing and Formulation Program (DMFP).
20-Jan-2015 - Catalent is taking aim at the Asian market with a partnership with Mitsubishi Gas Chemical Company to make cell lines for the region.
20-Jan-2015 - India-based CMO Piramal has acquired US-based sterile injectable CDMO (contract development and manufacturing organization) Coldstream Laboratories for $30.65m.
19-Jan-2015 - Hospira has announced it will close its plant in Clayton, North Carolina that it no longer deems cost effective for drug production.
19-Jan-2015 - Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.
16-Jan-2015 - Sanofi has selected Boehringer-Ingelheim to manufacture monoclonal antibodies in an agreement that extends to the French drugmaker's partner Regeneron.
16-Jan-2015 - CMO consolidation is resurrecting the ‘all-under-one-roof’ manufacturing model, but will firms fall into the same inefficiency pitfalls that drove pharma to outsource in the first place?
14-Jan-2015 - Lonza signed a flurry of biopharma-related deals and launched a number of drug industry services in the final quarter of 2014 as its efforts to focus on pharma intensified.
14-Jan-2015 - 2015 is the year that AMRI loses its royalties for discovering the API of Allegra and the company is now looking to its string of recent acquisitions and new contract...
13-Jan-2015 - AMRI has won a contract to develop and manufacture five parenteral generic products for Genovi Pharmaceuticals.
13-Jan-2015 - Fareva has added extra micronization capacity citing growing demand and the opportunity to work with customers earlier in the development process as the driver for the investment.
09-Jan-2015 - AMRI has paid $60m for two Aptuit facilities including an aseptic manufacturing site in Glasgow, UK which the firm says will boost its presence in Europe.
09-Jan-2015 - Hospira will resume the sale of infusion pumps from its troubled Costa Rica facility following the lifting of a US FDA import alert.
09-Jan-2015 - Falling oil prices are good news for firms that make pharmaceutical ingredients according to a European chemical industry group.
05-Jan-2015 - Injectable-heavy drug pipelines and increased biotech funding are driving up US demand for sterile manufacturing, according to UK-based Symbiosis, which is looking to help fill the gap left by several...
23-Dec-2014 - Bayer HealthCare and Cardinal Health have signed a 15-year agreement for the contract manufacturing of the castration-resistant prostate cancer drug Xofigo (radium Ra 223 dichloride).
22-Dec-2014 - Baxter has recalled two batches of saline injections after healthcare workers noticed parts of the vial had broken into the product.
19-Dec-2014 - The closure of an API plant in the UK will lead to opportunities for third party manufacturers, AstraZeneca has said.